Preoperative Carbohydrate Loading for Enhancing Recovery After Radical Cystectomy

Sponsor
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla (Other)
Overall Status
Recruiting
CT.gov ID
NCT05913245
Collaborator
(none)
66
1
3
15
4.4

Study Details

Study Description

Brief Summary

In recent years, the world of anesthesiology is questioning one of its great dogmas: Are so many hours of strict fasting necessary in patients who are candidates for elective surgeries? The main objective of our clinical trial will be demonstrate whether preoperative oral loading with hydrocarbonate beverages reduces the time of return of intestinal function in the postoperative period compared to water administration and strict fasting in patients undergoing elective radical cystectomy.

Condition or Disease Intervention/Treatment Phase
  • Dietary Supplement: Maltodextrin 12.5%
  • Other: Water
N/A

Detailed Description

Many anaesthesiology societies now recommend intake of clear fluids (water, tea or coffee without milk, juices without pulp) up to two hours before induction of anaesthesia for most patients undergoing elective surgery. This change the traditional practice of overnight fasting, while reducing thirst in the hours before surgery and seems to attenuate the response to the stress that results from a major operation, such as activation of endocrine and inflammatory systems which leads to tissue catabolism and insulin resistance. Among all the complications, one of the most frequent in patients undergoing mayor surgeries is undoubtedly paralytic ileus. The Enhanced Recovery After Surgery (ERAS) guidelines emphasize the importance of preventing this event. To prevent ileus, prokinetic agents such as metoclopramide are used, which although it has not been shown to shorten the period until the first flatulence or the first peristaltic movement, decrease nausea and vomiting. Chewing gum is another measure that is carried out, since it stimulates peristalsis and this measure if it had significant effects in time until first flatulence and in time until first peristaltic movement. In recent years there has been a great change in the perioperative management of patients who will undergo a radical cystectomy. The weight of traditional perioperative care has been an important barrier to the implementation of Fast Track (FT) protocols, since it is difficult to change a therapeutic strategy that has been carried out for decades. The positive results obtained in colorectal surgery led to Fast Track being implemented in other types of surgery similar to colorectal surgery such as radical cystectomy. Although there is apparently widespread enthusiasm for the implementation of Fast Track protocols, evidence of the use of this type of protocols in cystectomy is not robust, numerous studies claim that there is a big difference between the application of FT and the application of traditional measures in terms of length of hospital stay or complications. Because of this, more large-volume randomized experimental studies of patients are needed. This randomized double blind placebo-controlled trial of preoperative oral carbohydrate (CHO) treatment in patients undergoing elective radical cystectomy will investigate whether this treatment reduced the time of return of intestinal function. Secondary outcomes will be the incidence of infection of surgical wounds, the incidence of postoperative complications, the length of hospital stay and early postoperative fatigue in the three groups of patients undergoing this type of surgery.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
66 participants
Allocation:
Randomized
Intervention Model:
Single Group Assignment
Masking:
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Impact of the Preoperative Carbohydrate Loading for Enhancing Recovery After Radical Cystectomy: a Randomized Controlled Trial.
Actual Study Start Date :
Mar 30, 2023
Anticipated Primary Completion Date :
Jun 30, 2023
Anticipated Study Completion Date :
Jun 30, 2024

Arms and Interventions

Arm Intervention/Treatment
No Intervention: Fasting arm

Patients included in the fasting arm will not drink or eat anything after the dinner of the night before the surgery.

Active Comparator: Water arm

Patients included in the water intake arm will drink the same amount of mililiters than the carbohydrate loading drink.

Other: Water
Preoperative water

Experimental: Carbohydrate loading arm

Patients included in the intake arm of carbohydrate loading treatment should take 400ml the night before the intervention and 200ml the two hours before the intervention. The hydrocarbonate drink provided will be Sugarmix (Maltodextrin 12.5%).

Dietary Supplement: Maltodextrin 12.5%
Preoperative Maltodextrin 12.5%

Outcome Measures

Primary Outcome Measures

  1. Insulin resistance [1 Day of surgery]

    Determinate the insulin resistance measured by the homeostatic model assessment (HOMA) index.

Secondary Outcome Measures

  1. To determine the recovery time of intestinal activity by measuring time to first bowel movement. [1 week]

    Bowel movement

  2. To compare and determine whether there are differences between the incidence of infection of surgical wounds, the incidence of postoperative complications and the length of hospital stay in the three groups of patients undergoing this type of surgery. [Up to 30 days]

    Complications

  3. Insulin resistance [Postoperative day #1]

    Determinate the insulin resistance measured by the homeostatic model assessment

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Written informed consent.

  • Patients older than 18 years old proposed for radical cystectomy.

Exclusion Criteria:
  • American Society of Anesthesiologists (ASA) classification grade: IV

  • Renal failure (creatinine levels above 3 mg/dL or dialysis)

  • Liver failure (Child-Pugh B or higher)

  • Gastroesophageal reflux disease.

  • Gastrointestinal obstruction.

  • Ongoing treatment with corticosteroids.

  • Previous infections within the last 3 months.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Fundación Pública Andaluza para la Gestión de Investigación de Salud en Sevilla Seville Spain 41013

Sponsors and Collaborators

  • Fundación Pública Andaluza para la gestión de la Investigación en Sevilla

Investigators

  • Study Chair: Clara Rosso, PhD, Fundación Pública Andaluza para la gestión de la Investigación en Sevilla

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Daniel López-Herrera Rodriguez, PhD, Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
ClinicalTrials.gov Identifier:
NCT05913245
Other Study ID Numbers:
  • 1738-N-22
First Posted:
Jun 22, 2023
Last Update Posted:
Jun 22, 2023
Last Verified:
Jun 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Product Manufactured in and Exported from the U.S.:
No
Keywords provided by Daniel López-Herrera Rodriguez, PhD, Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 22, 2023